Submit Deal

Chris Boerner

CEO at BRISTOL MYERS SQUIBB COMPANY

Manager

Deal Bio

Total Deals8

Valued Deals7

Total Value£87,880M

Avg. Deal Size£12,554M

Market Context

Expertise (8)

Key Relationships

Sort

United States

Biotechnology

AcquisitionPublicMajorityDomestic

target

Celgene Corporation

bidder

Bristol Myers Squibb Company

£70,659m

83 dealmakers

United States

Biotechnology

MajorityDomesticPublicAcquisition

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

United States

Biotechnology

MergerPublicAcquisitionDomesticMajority

target

Karuna Therapeutics

bidder

Bristol Myers Squibb Company

£10,033m

55 dealmakers

United States

Biotechnology

AcquisitionDomesticMajorityPublicTender Offer

target

RAYZEBIO

bidder

Bristol Myers Squibb Company

£3,228m

36 dealmakers

United Kingdom

Pharmaceuticals

PrivatePrivate EquityAcquisitionCross BorderVenture CapitalMinority

target

Pathios Therapeutics

bidder

Bristol Myers Squibb Company

£20m

6 dealmakers

United States

Pharmaceuticals

AcquisitionPrivateCross BorderVenture CapitalPrivate EquityMinority

target

Accent Therapeutics

bidder

Mirae Asset Capital Co

£58m

15 dealmakers

United States

Pharmaceuticals

DomesticPrivateAcquisitionVenture CapitalMinority

target

Ratio Therapeutics

bidder

Duquesne Family Office

£39m

6 dealmakers

United States

Biotechnology

MinorityAcquisitionPrivateDomestic

target

Abata Therapeutics

bidder

Bristol Myers Squibb Company

value n/a

6 dealmakers

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.